Atara Biotherapeutics
8 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Systemic Lupus Erythematosus (NCT06429800) | Atara Biotherapeutics | 2025-04-16 |
| Phase 1/2 Study to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple Sclerosis (NCT03283826) | Atara Biotherapeutics | 2017-10-19 |
Track Atara Biotherapeutics automatically
Every clearance here is in the API, with alerts when new ones post.